Polymeric nanomicelles formulation of LY2157299-Galunisertib improves therapeutic outcome by greater reducing fibrosis and ameliorating fatty degeneration in a CCL4-induced hepatic-fibrosis rat-model

JOURNAL OF HEPATOLOGY(2022)

引用 0|浏览10
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要